SK7695A3 - Pharmacologicaly active alpha-(tertiary-aminomethyl)-benzene methanol derivatives - Google Patents

Pharmacologicaly active alpha-(tertiary-aminomethyl)-benzene methanol derivatives Download PDF

Info

Publication number
SK7695A3
SK7695A3 SK76-95A SK7695A SK7695A3 SK 7695 A3 SK7695 A3 SK 7695A3 SK 7695 A SK7695 A SK 7695A SK 7695 A3 SK7695 A3 SK 7695A3
Authority
SK
Slovakia
Prior art keywords
methyl
dimethylamino
methylethoxy
compound
group
Prior art date
Application number
SK76-95A
Other languages
English (en)
Slovak (sk)
Inventor
Nils-Erik Willman
Bengt C H Sjogren
Lennart G Nordh
Gustav L Persson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of SK7695A3 publication Critical patent/SK7695A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/70—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK76-95A 1992-07-22 1993-07-20 Pharmacologicaly active alpha-(tertiary-aminomethyl)-benzene methanol derivatives SK7695A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9202218A SE9202218D0 (sv) 1992-07-22 1992-07-22 Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
PCT/SE1993/000635 WO1994002442A1 (en) 1992-07-22 1993-07-20 PHARMACOLOGICALLY ACTIVE α-[TERTIARY-AMINOMETHYL]-BENZENEMETHANOL DERIVATIVES

Publications (1)

Publication Number Publication Date
SK7695A3 true SK7695A3 (en) 1995-07-11

Family

ID=20386825

Family Applications (1)

Application Number Title Priority Date Filing Date
SK76-95A SK7695A3 (en) 1992-07-22 1993-07-20 Pharmacologicaly active alpha-(tertiary-aminomethyl)-benzene methanol derivatives

Country Status (22)

Country Link
US (1) US5527821A (el)
EP (1) EP0651735B1 (el)
JP (1) JPH07509699A (el)
KR (1) KR950702522A (el)
CN (1) CN1085543A (el)
AT (1) ATE166339T1 (el)
AU (1) AU672989B2 (el)
BR (1) BR9306870A (el)
CA (1) CA2140781C (el)
CZ (1) CZ13395A3 (el)
DE (1) DE69318715D1 (el)
FI (1) FI950209A0 (el)
HU (1) HUT72632A (el)
MX (1) MX9304403A (el)
NO (1) NO301760B1 (el)
NZ (1) NZ254309A (el)
RU (1) RU2111205C1 (el)
SE (1) SE9202218D0 (el)
SK (1) SK7695A3 (el)
TW (1) TW261605B (el)
WO (1) WO1994002442A1 (el)
ZA (1) ZA935045B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
WO1998046216A1 (fr) * 1997-04-11 1998-10-22 Nippon Shinyaku Co., Ltd. Traitements des mictions frequentes et de l'incontinence urinaire
US6008412A (en) * 1997-10-14 1999-12-28 Eli Lilly And Company Process to make chiral compounds
US6323231B1 (en) 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
US6503190B1 (en) 2000-09-29 2003-01-07 Ethicon Endo-Surgery, Inc. Vaginal pessary
TW200510298A (en) * 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE210031C (el) *
US4349549A (en) * 1981-05-18 1982-09-14 Syntex (U.S.A.) Inc. Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s
PL140232B1 (en) * 1982-07-05 1987-04-30 Warszawskie Zaklady Farma Method of obtaining derivatives of 1-aryl-2-aminoestanole
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
EP0213108A3 (de) * 1985-06-26 1987-07-15 Kurt Dr. Burghart Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
PH30083A (en) * 1991-02-25 1996-12-27 Lilly Co Eli Treatment of lower urinary tract disorders

Also Published As

Publication number Publication date
ATE166339T1 (de) 1998-06-15
WO1994002442A1 (en) 1994-02-03
EP0651735A1 (en) 1995-05-10
FI950209A (fi) 1995-01-18
AU4595093A (en) 1994-02-14
RU95104934A (ru) 1997-04-10
DE69318715D1 (de) 1998-06-25
TW261605B (el) 1995-11-01
JPH07509699A (ja) 1995-10-26
MX9304403A (es) 1994-04-29
FI950209A0 (fi) 1995-01-18
HUT72632A (en) 1996-05-28
HU9500175D0 (en) 1995-03-28
NO301760B1 (no) 1997-12-08
CA2140781C (en) 1998-09-29
CA2140781A1 (en) 1994-02-03
ZA935045B (en) 1994-02-07
CZ13395A3 (en) 1995-11-15
NO950177L (no) 1995-01-17
NZ254309A (en) 1996-08-27
KR950702522A (ko) 1995-07-29
NO950177D0 (no) 1995-01-17
EP0651735B1 (en) 1998-05-20
US5527821A (en) 1996-06-18
SE9202218D0 (sv) 1992-07-22
AU672989B2 (en) 1996-10-24
BR9306870A (pt) 1998-12-08
RU2111205C1 (ru) 1998-05-20
CN1085543A (zh) 1994-04-20

Similar Documents

Publication Publication Date Title
JP3343256B2 (ja) 新規な３，３−ジフェニルプロピルアミン類、その使用および製造法
RU2213743C2 (ru) Производное тиенилазолилалкоксиэтанамина, способ его получения (варианты), фармацевтическая композиция, промежуточный продукт и способ его получения (варианты)
EP0125783B1 (en) Dopamine-beta-hydroxylase inhibitors
WO2002081453A1 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
JP2004527558A (ja) 重水素化３−ピペリジノプロピオフェノン及び該化合物を含有する医薬品
EP0047536B1 (en) Substituted propylamines
JP2009501229A (ja) 選択性の高いセロトニンおよびノルエピネフリン二重再取り込み阻害薬およびその使用
WO1996039133A1 (en) Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones
SK7695A3 (en) Pharmacologicaly active alpha-(tertiary-aminomethyl)-benzene methanol derivatives
WO1999002512A1 (en) Dl-2,3-diaryl-2h-1-benzopyrans
JP3606326B2 (ja) 欝病、不安神経症およびパーキンソン病を治療するための１−アリールシクロアルキルスルフィド、スルホキシドおよびスルホン
EP0284914B1 (de) Benzofuranderivate und diese enthaltende therapeutische Mittel
FR2658821A1 (fr) Nouvelles propanamines, leurs proprietes pharmacologiques et leur application a des fins therapeutiques, notamment antidiarrheuiques.
SK9802002A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives, the method for the production thereof, medicaments comprising said substances and their use
EP0037344B1 (fr) Amino-alcoxy pyrazoles, procédé pour leur préparation, et médicaments les contenant
JP2003519115A (ja) 置換１−および２−ナフトールマンニッヒ塩基
SK6412000A3 (en) Biphenyl derivatives as pharmaceuticals
FR2694287A1 (fr) Nouvelles cycloalkylalkylamines ligands aux récepteurs sigma, leur procédé de préparation et leur application en thérapeutique.
FR2594335A1 (fr) Derives de 5-(2-piperazinoethyl)-thiazole en tant que medicaments utiles en urologie
EP0061406A1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
KR820001304B1 (ko) 펜아탄올아민의 제조방법
JPS59176235A (ja) １−（２−ヒドロキシフエニル）−３−フエニルプロパノ−ルの新規誘導体、その製法及び用途
FR2690916A1 (fr) Nouveaux énantiomères dérivés du (S)-amino-2-(dichloro-3,4-benzyl)-2-propanol-1.
FR2618780A1 (fr) Derives du thiazole appartenant a la famille des 2-piperazinoacetamido-4-methylthiazoles, procede de preparation et utilisation en therapeutique